300435.SZ
Hangzhou Zhongtai Cryogenic Technology Corporation [300435.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
300435.SZ Stock Summary
Top 10 Correlated Stocks
300435.SZ
In the News
300435.SZ Financial details
Company Rating
Buy
Market Cap
5.11B
Income
320.06M
Revenue
3.12B
Book val./share
8.02
Cash/share
4.36
Dividend
0.1
Dividend %
0.73%
Employees
1.11K
Optionable
No
Shortable
Yes
Earnings
24 Oct 2023
P/E
18.3
Forward P/E
-
PEG
6.26
P/S
1.67
P/B
1.91
P/C
3.19
P/FCF
262.04
Quick Ratio
1.3
Current Ratio
1.43
Debt / Equity
0.35
LT Debt / Equity
0
-
-
EPS (TTM)
0.84
EPS next Y
-
EPS next Q
-
EPS this Y
12.31%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
21.12%
Revenue last 5Y
40.5%
Revenue Q/Q
-19.38%
EPS Q/Q
-33.33%
-
-
-
-
SMA20
-
SMA50
8.33%
SMA100
-7.14%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
11%
ROC
0.12%
Gross Margin
18%
Oper. Margin
12%
Profit Margin
10%
Payout
20%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.41-16.29
52W High
-13%
52W Low
+39.2%
RSI
58
Rel Volume
1.95
Avg Volume
4.37M
Volume
8.52M
Perf Week
5.45%
Perf Month
3.8%
Perf Quarter
2.58%
Perf Half Y
-5.69%
-
-
-
-
Beta
0.608
-
-
Volatility
0.26%, 0.22%
Prev Close
2.81%
Price
13.92
Change
2.96%
300435.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.43 | 3.87 | 5.23 | 6.36 | 8.56 | |
| Net income per share | 0.28 | 0.29 | 0.52 | 0.65 | 0.73 | |
| Operating cash flow per share | 0.42 | 0.49 | 1.11 | 0.83 | 0.76 | |
| Free cash flow per share | 0.36 | 0.46 | 0.36 | 0.27 | 0.07 | |
| Cash per share | 1.95 | 1.37 | 1.98 | 2.5 | 3.37 | |
| Book value per share | 3.32 | 7.89 | 6.07 | 6.67 | 7.41 | |
| Tangible book value per share | 3.19 | 5.09 | 3.93 | 4.58 | 5.35 | |
| Share holders equity per share | 3.32 | 7.89 | 6.07 | 6.67 | 7.41 | |
| Interest debt per share | 0.64 | 0.66 | 0.7 | 0.86 | 1.8 | |
| Market cap | 2.36B | 2.87B | 4.9B | 8.85B | 5.08B | |
| Enterprise value | 2.25B | 2.79B | 4.41B | 8.32B | 4.46B | |
| P/E ratio | 34.93 | 37.1 | 24.99 | 36.07 | 18.27 | |
| Price to sales ratio | 3.97 | 2.78 | 2.48 | 3.68 | 1.56 | |
| POCF ratio | 23.03 | 22 | 11.69 | 28.1 | 17.62 | |
| PFCF ratio | 26.53 | 23.55 | 35.79 | 87.56 | 184.71 | |
| P/B Ratio | 2.9 | 1.36 | 2.14 | 3.51 | 1.8 | |
| PTB ratio | 2.9 | 1.36 | 2.14 | 3.51 | 1.8 | |
| EV to sales | 3.79 | 2.69 | 2.23 | 3.46 | 1.37 | |
| Enterprise value over EBITDA | 23.08 | 17.26 | 12.54 | 20.25 | 8.91 | |
| EV to operating cash flow | 21.95 | 21.34 | 10.52 | 26.41 | 15.46 | |
| EV to free cash flow | 25.3 | 22.84 | 32.21 | 82.3 | 162.15 | |
| Earnings yield | 0.03 | 0.03 | 0.04 | 0.03 | 0.05 | |
| Free cash flow yield | 0.04 | 0.04 | 0.03 | 0.01 | 0.01 | |
| Debt to equity | 0.18 | 0.08 | 0.11 | 0.12 | 0.24 | |
| Debt to assets | 0.11 | 0.06 | 0.07 | 0.08 | 0.14 | |
| Net debt to EBITDA | -1.13 | -0.54 | -1.4 | -1.29 | -1.24 | |
| Current ratio | 1.85 | 1.97 | 1.78 | 1.56 | 1.49 | |
| Interest coverage | 9.35 | 14.21 | 29.09 | 24.97 | 15.97 | |
| Income quality | 1.59 | 1.69 | 2.17 | 1.28 | 1.04 | |
| Dividend Yield | 0.02 | 0.01 | 0.01 | 0 | 0.01 | |
| Payout ratio | 0.84 | 0.29 | 0.14 | 0.18 | 0.18 | |
| Sales general and administrative to revenue | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | |
| Research and developement to revenue | 0.04 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.02 | 0.26 | 0.23 | 0.2 | 0.17 | |
| Capex to operating cash flow | -0.13 | -0.07 | -0.67 | -0.68 | -0.9 | |
| Capex to revenue | -0.02 | -0.01 | -0.14 | -0.09 | -0.08 | |
| Capex to depreciation | -1.23 | -0.37 | -4.36 | -2.65 | -3.04 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0.01 | |
| Graham number | 4.55 | 7.18 | 8.41 | 9.87 | 11.03 | |
| ROIC | 0.06 | 0.05 | 0.08 | 0.08 | 0.08 | |
| Return on tangible assets | 0.05 | 0.04 | 0.07 | 0.08 | 0.07 | |
| Graham Net | 1.33 | 0.87 | 0.76 | 0.77 | 0.7 | |
| Working capital | 491.13M | 724.15M | 778.6M | 725.2M | 834M | |
| Tangible asset value | 781.63M | 1.36B | 1.49B | 1.73B | 2.04B | |
| Net current asset value | 464.71M | 697.34M | 627.45M | 637.38M | 665.58M | |
| Invested capital | 0.18 | 0.08 | 0.11 | 0.12 | 0.24 | |
| Average receivables | 489.11M | 596.9M | 754.18M | 783M | 863.23M | |
| Average payables | 150.62M | 209.5M | 273.23M | 314.73M | 363.24M | |
| Average inventory | 167.64M | 190.93M | 192.01M | 247.56M | 282.5M | |
| Days sales outstanding | 283.52 | 258.25 | 143.33 | 119.72 | 105.02 | |
| Days payables outstanding | 138.59 | 113.68 | 68.98 | 62.41 | 53.12 | |
| Days of inventory on hand | 170.88 | 79.03 | 48.92 | 53.37 | 37.82 | |
| Receivables turnover | 1.29 | 1.41 | 2.55 | 3.05 | 3.48 | |
| Payables turnover | 2.63 | 3.21 | 5.29 | 5.85 | 6.87 | |
| Inventory turnover | 2.14 | 4.62 | 7.46 | 6.84 | 9.65 | |
| ROE | 0.08 | 0.04 | 0.09 | 0.1 | 0.1 | |
| Capex per share | -0.06 | -0.03 | -0.75 | -0.57 | -0.69 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.06 | 2.28 | 2.5 | 1.89 | 1.51 | |
| Net income per share | 0.21 | 0.16 | 0.18 | 0.3 | 0.2 | |
| Operating cash flow per share | 0.21 | 0.16 | 0.18 | 0.27 | 0.11 | |
| Free cash flow per share | 0.02 | -0.05 | 0 | 0.11 | -0.01 | |
| Cash per share | 3.72 | 3.37 | 3.63 | 4.36 | 4.36 | |
| Book value per share | 7.22 | 7.41 | 7.61 | 7.82 | 8.02 | |
| Tangible book value per share | 5.18 | 5.35 | 5.57 | 5.82 | 6.04 | |
| Share holders equity per share | 7.22 | 7.41 | 7.61 | 7.82 | 8.02 | |
| Interest debt per share | 2 | 1.76 | 2.19 | 2.88 | 2.86 | |
| Market cap | 5.1B | 5.08B | 5.84B | 5.51B | 5.65B | |
| Enterprise value | 4.44B | 4.46B | 5.28B | 4.93B | 5.07B | |
| P/E ratio | 16.17 | 20.98 | 20.89 | 12.04 | 18.76 | |
| Price to sales ratio | 6.5 | 5.86 | 6.13 | 7.65 | 9.74 | |
| POCF ratio | 64.68 | 83.9 | 83.57 | 53.7 | 136.26 | |
| PFCF ratio | 723.46 | -274.24 | -5.66K | 127.44 | -1.5K | |
| P/B Ratio | 1.86 | 1.8 | 2.01 | 1.85 | 1.84 | |
| PTB ratio | 1.86 | 1.8 | 2.01 | 1.85 | 1.84 | |
| EV to sales | 5.66 | 5.14 | 5.55 | 6.85 | 8.73 | |
| Enterprise value over EBITDA | 33.84 | 48.16 | 61.95 | 33.56 | 46.55 | |
| EV to operating cash flow | 56.28 | 73.66 | 75.63 | 48.1 | 122.23 | |
| EV to free cash flow | 629.56 | -240.75 | -5.12K | 114.15 | -1.35K | |
| Earnings yield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0.01 | 0 | |
| Debt to equity | 0.27 | 0.24 | 0.29 | 0.36 | 0.35 | |
| Debt to assets | 0.16 | 0.14 | 0.17 | 0.21 | 0.21 | |
| Net debt to EBITDA | -5.05 | -6.7 | -6.51 | -3.91 | -5.34 | |
| Current ratio | 1.58 | 1.49 | 1.49 | 1.41 | 1.43 | |
| Interest coverage | 13.85 | 12.37 | 13.24 | 17.3 | 12.6 | |
| Income quality | 1 | 1 | 1 | 0.9 | 0.55 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0.23 | 0.1 | 0.07 | 0.42 | 0.09 | |
| Sales general and administrative to revenue | 0.06 | -0.02 | 0.02 | 0 | 0.09 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Intangibles to total assets | 0.17 | 0.17 | 0.16 | 0.15 | 0.15 | |
| Capex to operating cash flow | -0.91 | -1.31 | -1.01 | -0.58 | -1.09 | |
| Capex to revenue | -0.09 | -0.09 | -0.07 | -0.08 | -0.08 | |
| Capex to depreciation | 1.66 | -3.57 | -3.91 | -3.27 | 1.03 | |
| Stock based compensation to revenue | -0.02 | 0.04 | 0 | 0.01 | -0.01 | |
| Graham number | 5.8 | 5.15 | 5.6 | 7.27 | 5.96 | |
| ROIC | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
| Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
| Graham Net | 1.11 | 0.7 | 0.76 | 0.96 | 1.07 | |
| Working capital | 953.9M | 834M | 883.63M | 840.06M | 915.35M | |
| Tangible asset value | 1.97B | 2.04B | 2.12B | 2.22B | 2.31B | |
| Net current asset value | 783.44M | 665.58M | 716.25M | 773.32M | 846.84M | |
| Invested capital | 0.27 | 0.24 | 0.29 | 0.36 | 0.35 | |
| Average receivables | 912.37M | 943.89M | 945.55M | 947.56M | 1.02B | |
| Average payables | 317.16M | 363.41M | 368.05M | 341.56M | 364.68M | |
| Average inventory | 235.56M | 256.39M | 290.3M | 277.58M | 247.19M | |
| Days sales outstanding | 109.04 | 97.31 | 90.23 | 117.62 | 168.98 | |
| Days payables outstanding | 49.37 | 47.88 | 37.25 | 56.31 | 80.92 | |
| Days of inventory on hand | 34.46 | 34.08 | 32.66 | 42.12 | 49.89 | |
| Receivables turnover | 0.83 | 0.92 | 1 | 0.77 | 0.53 | |
| Payables turnover | 1.82 | 1.88 | 2.42 | 1.6 | 1.11 | |
| Inventory turnover | 2.61 | 2.64 | 2.76 | 2.14 | 1.8 | |
| ROE | 0.03 | 0.02 | 0.02 | 0.04 | 0.02 | |
| Capex per share | -0.19 | -0.21 | -0.19 | -0.16 | -0.12 |
300435.SZ Frequently Asked Questions
What is Hangzhou Zhongtai Cryogenic Technology Corporation stock symbol ?
Hangzhou Zhongtai Cryogenic Technology Corporation is a CN stock and trading under the symbol 300435.SZ
What is Hangzhou Zhongtai Cryogenic Technology Corporation stock quote today ?
Hangzhou Zhongtai Cryogenic Technology Corporation stock price is $13.92 today.
Is Hangzhou Zhongtai Cryogenic Technology Corporation stock public?
Yes, Hangzhou Zhongtai Cryogenic Technology Corporation is a publicly traded company.
Company Profile
- Volume Average 4.37M
- Market Capitalization 5.11B
- Employee 1.11K
- CEO Mr. Youhu Zhang
- Headquarters Hangzhou,CN
- IPO Date 2015-03-26
-
Website
https://www.zhongtaihangzhou.com 
Hangzhou Zhongtai Cryogenic Technology Corporation develops, designs, manufactures, and sells cryogenic equipment in China. The company offers packaged units, such as cryogenic liquefaction plants for liquefied natural gas; cryogenic purification plants for liquid nitrogen washing devices; and cryogenic separation plants for H2-CO separation units. It also provides cold box products that include liquefied natural gas, liquid nitrogen washing, ethylene, air separation unit, propane dehydrogenation propylene, methanol to olefins/methanol to propylene, and carbon monoxide cold boxes. In addition, the company offers plate-fin heat exchangers, such as aluminum plate-fin heat exchangers and ethylene column overhead condensers/plate-fin vessels. It serves customers in the energy, chemical, metallurgy, electric power, liquefied natural gas, and modern coal chemical industries. It also exports its products to the United State, Europe, India, etc. Hangzhou Zhongtai Cryogenic Technology Corporation was founded in 2006 and is based in Hangzhou, China.
